Chinese Officials Look For Source Of Avastin In Adverse Reaction Incident
This article was originally published in PharmAsia News
Executive Summary
Chinese patients at a Shanghai hospital received Avastin (bevacizumab) for treatment of macular degeneration, but 61 of the 116 patients suffered adverse drug reactions